Alliance Pharma
Alliance Pharma is an established healthcare institution whose principal relevance to this ranking lies in pharmaceutical analytical testing and contract laboratory services. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in clinical Trial & Research Laboratories.
The bioanalytical CRO Alliance Pharma and Drug Development Solutions adopted the Resolian name in May 2023, following the acquisition of the UK laboratory business in 2022. Alliance Pharma’s own company release dates its founding to 2008. This laboratory business provides bioanalysis, DMPK and analytical and materials science services. Resolian identifies Malvern, Pennsylvania as headquarters. Ampersand Capital Partners and KKR became equal shareholders following the completed 2022 combination and were still identified as backers in 2024.
- Highest 2026 tier: Tier III
- Clinical Trial & Research Laboratories
- 1 ranking category
Overview
Alliance Pharma is an established healthcare institution whose principal relevance to this ranking lies in pharmaceutical analytical testing and contract laboratory services. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in clinical Trial & Research Laboratories.
Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Alliance Pharma contributes a credible combination of these characteristics.
Published assessment: Top 30 Clinical Trial & Research Laboratories 2026 — Alliance Pharma.
Firm facts
| Public identity | Alliance Pharma |
| Institution type | Clinical Trial & Research Laboratories institution |
| Primary focus | Clinical Trial & Research Laboratories |
| Highest 2026 ranking tier | Tier III |
Contents
Activities in published assessments
Top 30 Clinical Trial & Research Laboratories 2026 — Alliance Pharma
Alliance Pharma is an established healthcare institution whose principal relevance to this ranking lies in pharmaceutical analytical testing and contract laboratory services. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in clinical Trial & Research Laboratories.
Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Alliance Pharma contributes a credible combination of these characteristics.
Principal activities
Alliance Pharma is assessed using public institutional information and category-specific editorial research.
Core capability
Clinical Trial & Research Laboratories
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
Clinical Trial & Research Laboratories
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
Alliance Pharma is assessed using public institutional information and category-specific editorial research.
Alliance Pharma is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier III.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. Alliance Pharma should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as Alliance Pharma. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | Alliance Pharma |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 Clinical Trial & Research Laboratories 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
Corrections and Updates
Factual corrections, updated institutional information, and supporting references may be submitted through The Economy Portal. All proposed changes are subject to editorial verification before publication.